argenx SE (ARGX) PT Raised at Piper Sandler Following Successful Seronegative gMG Readout
Tweet Send to a Friend
Piper Sandler analyst Allison M. Bratzel raised the price target on argenx SE (NASDAQ: ARGX) to $820.00 (from $750.00) while ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
